Literature DB >> 21672532

Lipoprotein(a)-cholesterol: a significant component of serum cholesterol.

Kiyoko Kinpara1, Hiroshi Okada, Akiko Yoneyama, Minoru Okubo, Toshio Murase.   

Abstract

BACKGROUND: Lipoprotein(a) [Lp(a)] is known to be a cholesterol-rich lipoprotein, however, the contribution of Lp(a)-cholesterol [Lp(a)-C] to the serum cholesterol and LDL-C levels has not yet been fully evaluated.
METHODS: We determined the serum Lp(a)-C in 55 subjects with serum Lp(a) concentrations ranging from 9 to 129 mg/dl. To measure the serum Lp(a)-C concentrations, we developed an immunoaffinity gel assay; serum was incubated with Sepharose 4B gel coupled with immunoglobulin G (IgG) prepared from a polyclonal anti-Lp(a) goat antiserum. After separating Lp(a) from other lipoproteins, we determined the serum Lp(a)-C concentrations. Validation of the assay showed satisfactory results in terms of the specificity and reproducibility.
RESULTS: The mean cholesterol content of Lp(a), determined as Lp(a)-C/Lp(a), was 29.5±10.4%. The serum Lp(a)-C values were found to be highly correlated with the serum Lp(a) mass (r=0.923, p<0.001). At serum Lp(a) levels of over 50mg/dl, the contribution of Lp(a)-C to the serum total cholesterol was 10.2%. Further, the Friedewald formula overestimated the serum LDL-C by 20.4%.
CONCLUSIONS: Lp(a) contains approximately 30% cholesterol in each molecule. In subjects with markedly elevated serum Lp(a) concentrations, the Lp(a)-C values should be taken into account when evaluating the serum LDL-C.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21672532     DOI: 10.1016/j.cca.2011.05.036

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  16 in total

Review 1.  Familial Hypercholesterolemia and Lipoprotein(a): Two Partners in Crime?

Authors:  Rodrigo Alonso; Rosa Argüeso; Pilar Álvarez-Baños; Ovidio Muñiz-Grijalvo; Jose Luis Diaz-Diaz; Pedro Mata
Journal:  Curr Atheroscler Rep       Date:  2022-04-07       Impact factor: 5.113

2.  Lipoprotein(a) in Children of Asian Indian Descendants and Their Caucasian Neighbors: The Slovak Lipid Community Study.

Authors:  R Alberty; D Albertyová
Journal:  Indian J Clin Biochem       Date:  2012-03-10

3.  Elevated lipoprotein(a) and familial hypercholesterolemia in the coronary care unit: Between Scylla and Charybdis.

Authors:  Katrina L Ellis; Jing Pang; David Chieng; Damon A Bell; John R Burnett; Carl J Schultz; Graham S Hillis; Gerald F Watts
Journal:  Clin Cardiol       Date:  2018-02-26       Impact factor: 2.882

4.  Effectiveness of proprotein convertase subtilisin/kexin-9 monoclonal antibody treatment on plasma lipoprotein(a) concentrations in patients with elevated lipoprotein(a) attending a clinic.

Authors:  Anindita Chakraborty; Jing Pang; Dick C Chan; Wendy Barnett; Ann Marie Woodward; Mary Vorster; Gerald F Watts
Journal:  Clin Cardiol       Date:  2021-05-06       Impact factor: 3.287

5.  Assessing the Accuracy of Estimated Lipoprotein(a) Cholesterol and Lipoprotein(a)-Free Low-Density Lipoprotein Cholesterol.

Authors:  Weili Zheng; Michael Chilazi; Jihwan Park; Vasanth Sathiyakumar; Leslie J Donato; Jeffrey W Meeusen; Mariana Lazo; Eliseo Guallar; Krishnaji R Kulkarni; Allan S Jaffe; Raul D Santos; Peter P Toth; Steven R Jones; Seth S Martin
Journal:  J Am Heart Assoc       Date:  2022-01-13       Impact factor: 6.106

6.  Genetic Factors Explain a Major Fraction of the 50% Lower Lipoprotein(a) Concentrations in Finns.

Authors:  Gertraud Erhart; Claudia Lamina; Terho Lehtimäki; Pedro Marques-Vidal; Mika Kähönen; Peter Vollenweider; Olli T Raitakari; Gérard Waeber; Barbara Thorand; Konstantin Strauch; Christian Gieger; Thomas Meitinger; Annette Peters; Florian Kronenberg; Stefan Coassin
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-03-22       Impact factor: 8.311

7.  Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment.

Authors:  Gregory G Schwartz; Michael Szarek; Vera A Bittner; Deepak L Bhatt; Rafael Diaz; Shaun G Goodman; J Wouter Jukema; Megan Loy; Garen Manvelian; Robert Pordy; Harvey D White; Philippe Gabriel Steg
Journal:  Diabetes Care       Date:  2021-03-15       Impact factor: 19.112

8.  Lipoprotein(a).

Authors:  Florian Kronenberg
Journal:  Handb Exp Pharmacol       Date:  2022

9.  Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points-a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine.

Authors:  Børge G Nordestgaard; Anne Langsted; Samia Mora; Genovefa Kolovou; Hannsjörg Baum; Eric Bruckert; Gerald F Watts; Grazyna Sypniewska; Olov Wiklund; Jan Borén; M John Chapman; Christa Cobbaert; Olivier S Descamps; Arnold von Eckardstein; Pia R Kamstrup; Kari Pulkki; Florian Kronenberg; Alan T Remaley; Nader Rifai; Emilio Ros; Michel Langlois
Journal:  Eur Heart J       Date:  2016-04-26       Impact factor: 29.983

10.  A genome-wide association meta-analysis on lipoprotein (a) concentrations adjusted for apolipoprotein (a) isoforms.

Authors:  Salome Mack; Stefan Coassin; Rico Rueedi; Noha A Yousri; Ilkka Seppälä; Christian Gieger; Sebastian Schönherr; Lukas Forer; Gertraud Erhart; Pedro Marques-Vidal; Janina S Ried; Gerard Waeber; Sven Bergmann; Doreen Dähnhardt; Andrea Stöckl; Olli T Raitakari; Mika Kähönen; Annette Peters; Thomas Meitinger; Konstantin Strauch; Ludmilla Kedenko; Bernhard Paulweber; Terho Lehtimäki; Steven C Hunt; Peter Vollenweider; Claudia Lamina; Florian Kronenberg
Journal:  J Lipid Res       Date:  2017-05-16       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.